*0014364
*00520190321131412.0
*007ta
*008061109s1998    xx#           000 u eng d
*00901010cam a2200301 c 4500
*019  $bl
*020  $a0929375181$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)999918077314702201
*035  $a(NO-LaBS)14423116(bibid)
*035  $a(NO-TrBIB)991807731
*035  $a991807731-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*060 4$aQV 704
*084  $a4.92$qNoOU$2farma
*24500$aPharmacoepidemiology :$ban introduction$cedited by Abraham G. Hartzema, Miquel Porta, and Hugh H. Tilson
*250  $a3rd ed.
*260  $aCincinnati, Ohio$bHarvey Whitney Books$cc1998
*300  $aXVIII, 670 s.$bfig.
*650 2$aEpidemiology$_10544600
*650 2$aPharmacy$_11608500
*650 7$aKlinisk farmakologi$0(NO-TrBIB)REAL006512$2noubomn$_195101200
*650 7$aLegemidler$0(NO-TrBIB)REAL013959$2noubomn$_185634200
*653  $alegemidler$afarmakoepidemiologi$_11608800
*7001 $aHartzema, Abraham G.$0(NO-TrBIB)90586116$_11608900
*7001 $aPorta, Miquel S.$0(NO-TrBIB)90586117$_11609000
*7001 $aTilson, Hugh H.$0(NO-TrBIB)90586118$_11609100
*901  $a80
*999  $aoai:nb.bibsys.no:999920151495502202$b2021-11-14T19:39:19Z$z999920151495502202
^